CannaPharmaRX, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 8.53 million compared to USD 8.83 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.12 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | 0.00% |
|
-9.09% | +488.24% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+488.24% | 6.56M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- CPMD Stock
- News CannaPharmaRX, Inc.
- CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022